Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Transitional Cell Cancer of the Renal Pelvis and Ureter”

112 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 112 results

Testing effectiveness (Phase 2)Study completedNCT04672330
What this trial is testing

Neoadjuvant PD-1 Monoclonal Antibody in Cisplatin-ineligible High Risk Upper Tract Urothelial Carcinoma

Who this might be right for
Neoadjuvant Immunotherapy of Cisplatin-ineligible High Risk Upper Urinary Tract Urothelial Carcinoma
RenJi Hospital 16
Testing effectiveness (Phase 2)Study completedNCT00009867
What this trial is testing

Arsenic Trioxide in Treating Patients With Urothelial Cancer

Who this might be right for
Recurrent Transitional Cell Cancer of the Renal Pelvis and UreterRecurrent Urethral CancerTransitional Cell Carcinoma of the Bladder+1 more
National Cancer Institute (NCI) 35
Testing effectiveness (Phase 2)Looking for participantsNCT06354231
What this trial is testing

DV Combined With Toripalimab for Renal Preservation in Solitary Kidney or Renal Insufficiency or Bilateral Multiple UTUC

Who this might be right for
Renal InsufficiencyUpper Urinary Tract Urothelial CarcinomaSolitary Kidney
Fudan University 20
Large-scale testing (Phase 3)Looking for participantsNCT04628767
What this trial is testing

Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer

Who this might be right for
Renal Pelvis and Ureter Urothelial Carcinoma
National Cancer Institute (NCI) 131
Not applicableUnknownNCT04944550
What this trial is testing

New Models for the Evaluation of Preclinical Treatment for Urothelial Carcinomas of the Upper Excretory Tract.

Who this might be right for
Upper Urinary Tract Urothelial CarcinomaNephroureterectomyTumor+1 more
Centre Hospitalier Universitaire de Nīmes 20
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)Study completedNCT00066612
What this trial is testing

S0306, Irinotecan in Treating Patients With Recurrent or Refractory Advanced Transitional Cell Cancer of the Urothelium Previously Treated With Chemotherapy

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
SWOG Cancer Research Network 45
Testing effectiveness (Phase 2)Study completedNCT00005644
What this trial is testing

Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium and Decreased Kidney Function

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
Eastern Cooperative Oncology Group
Not applicableLooking for participantsNCT06169436
What this trial is testing

Translational Cancer Observational Protocol

Who this might be right for
Upper Urinary Tract Urothelial Carcinoma
IRCCS San Raffaele 1,250
Testing effectiveness (Phase 2)UnknownNCT03209206
What this trial is testing

The Effectiveness and Safety of Intravesical Docetaxel Instillation for Prevent Bladder Recurrence

Who this might be right for
Urothelial Carcinoma
Seoul National University Hospital 84
Early research (Phase 1)Study completedNCT00004074
What this trial is testing

Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu

Who this might be right for
Advanced Adult Primary Liver CancerAnaplastic Thyroid CancerBone Metastases+124 more
National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)Looking for participantsNCT07087860
What this trial is testing

Therapeutic Plasma Exchange With Enfortumab Vedotin and Pembrolizumab for Treatment of Bladder Cancers

Who this might be right for
Metastatic Bladder Urothelial CarcinomaMetastatic Renal Pelvis and Ureter Urothelial CarcinomaRefractory Bladder Urothelial Carcinoma+3 more
Mayo Clinic 70
Testing effectiveness (Phase 2)Looking for participantsNCT06822010
What this trial is testing

SeqUential GeMcitabine and MITomycin Treatment for Favorable High-Risk Upper Urinary Tract Urothelial Carcinoma

Who this might be right for
Urinary Bladder CancerUpper Tract Urothelial CancerUrothelial Cancer
Rutgers, The State University of New Jersey 28
Large-scale testing (Phase 3)Looking for participantsNCT06124976
What this trial is testing

Multicenter Clinical Trial of ST-02 for Ablation of Upper Tract Urothelial Carcinoma

Who this might be right for
Urothelial Carcinoma of the Renal Pelvis and UreterTransitional Cell Cancer of the Renal Pelvis and Ureter
University of British Columbia 70
Testing effectiveness (Phase 2)Study completedNCT00053209
What this trial is testing

Pemetrexed Disodium and Gemcitabine in Treating Patients With Advanced Cancer of the Urothelium

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
Eastern Cooperative Oncology Group 46
Testing effectiveness (Phase 2)Ended earlyNCT04228042
What this trial is testing

Infigratinib Before Surgery for the Treatment of Upper Tract Urothelial Cancer

Who this might be right for
Renal Pelvis and Ureter Urothelial Carcinoma
M.D. Anderson Cancer Center 15
Testing effectiveness (Phase 2)Study completedNCT00045630
What this trial is testing

S0219, Combination Chemotherapy Followed By Observation or Surgery in Patients With Stage II or Stage III Cancer of the Urothelium

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
SWOG Cancer Research Network 77
Testing effectiveness (Phase 2)Study completedNCT02567409
What this trial is testing

Cisplatin and Gemcitabine Hydrochloride With or Without Berzosertib in Treating Patients With Metastatic Urothelial Cancer

Who this might be right for
Metastatic Bladder Urothelial CarcinomaMetastatic Renal Pelvis and Ureter Urothelial CarcinomaMetastatic Ureter Urothelial Carcinoma+1 more
National Cancer Institute (NCI) 87
Early research (Phase 1)Study completedNCT02443324
What this trial is testing

Ramucirumab Plus Pembrolizumab in Participants With Gastric or GEJ Adenocarcinoma, NSCLC, Transitional Cell Carcinoma of the Urothelium, or Biliary Tract Cancer

Who this might be right for
Gastric AdenocarcinomaAdenocarcinoma of the Gastroesophageal JunctionNon-small Cell Lung Cancer+2 more
Eli Lilly and Company 175
Not applicableStudy completedNCT01846520
What this trial is testing

Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers

Who this might be right for
Healthy SubjectLocalized Transitional Cell Cancer of the Renal Pelvis and UreterMetastatic Transitional Cell Cancer of the Renal Pelvis and Ureter+81 more
City of Hope Medical Center 200
Load More Results